Transforming Trial Success: AI’s Role in Clinical Trial Meta-Analysis
Published research and literature-based content holds valuable insight that can inform clinical trial execution and…
CertaraApril 19, 2023
Solubility prediction – Chemaxon’s Solubility Predictor
Aqueous solubility for organic compounds is one of the most important physico-chemical properties in modern…
CertaraApril 19, 2023
Predicting pKa | ChemAxon
One of the most important physicochemical properties of small molecules and macromolecules are the dissociation…
CertaraApril 19, 2023
Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development
Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…
CertaraApril 17, 2023
Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial
Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…
CertaraApril 17, 2023
Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program
This white paper focuses on best practices for developing a CMC strategy for orally administered…
CertaraApril 13, 2023
Repurposing Data & Advanced Analytics to Validate Surrogate Endpoints
Repurposed data and advanced analytics can be used to validate a surrogate endpoint. A surrogate…
CertaraApril 13, 2023
LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data
Published: April 12, 2023 This is the German article written by Dr. Fabian Rauscher, Scientific…
CertaraApril 12, 2023
EDB GlobalConnect Certified Technology Partnership
We are excited to announce that Chemaxon is now an EDB GlobalConnect Certified Technology Partner.
CertaraApril 12, 2023
